It is a pharma public limited company based in Ahmedabad, Gujarat, India, established in 2013.
2013 | Ahmedabad, Gujarat, India | ActiveRexroth Pharmaceutical Limited, a active public limited company, was established on 15 May 2013 in Ahmedabad, Gujarat, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24232GJ2013PLC075081. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Ketankumar Hashmukhlal Trivedi (Director), Sanjaykumar Shankarlal Shah (Director), Sanjaykumar Hasmukhlal Trivedi (Director). Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at A/7, First Floor, Verai Estate, B/H Kanchan Pharma B/H Shell Petrol Pump, N.H. No 8, Aslali, Ahmedabad, Gujarat, 382427.
U24232GJ2013PLC075081
075081
15 May 2013
₹0.50 M
₹0.50 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Rexroth Pharmaceutical Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ketankumar Hashmukhlal Trivedi | Director | 15 May 2013 | Current |
| Sanjaykumar Shankarlal Shah | Director | 15 May 2013 | Current |
| Sanjaykumar Hasmukhlal Trivedi | Director | 15 May 2013 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rexroth Pharmaceutical Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 1.3% decrease in profit. The company's net worth dipped by a decrease of 1.93%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
In 2016, Rexroth Pharmaceutical had a promoter holding of 99.20% and a public holding of 0.80%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Rexroth Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Rexroth Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rexroth Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Rexroth Pharmaceutical Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was recorded as a recent event.
Progress on Rexroth Pharmaceutical Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Ahmedabad. was documented.
Ketankumar Hashmukhlal Trivedi was appointed as a Director was appointed as a Director on 15 May 2013 & has been associated with this company since 12 years 7 months . was recorded as a recent event.
The activity Sanjaykumar Shankarlal Shah was appointed as a Director was appointed as a Director on 15 May 2013 & has been associated with this company since 12 years 7 months . was completed.
Progress on Sanjaykumar Hasmukhlal Trivedi was appointed as a Director was appointed as a Director on 15 May 2013 & has been associated with this company since 12 years 7 months . was documented.
The activity Rexroth Pharmaceutical Limited was registered on 15 May 2013 with Roc Ahmedabad & aged 12 years 7 months as per MCA records. was completed.
The CIN of Rexroth Pharmaceutical Limited is U24232GJ2013PLC075081.
Rexroth Pharmaceutical Limited is headquartered at A/7, First Floor, Verai Estate, B/H Kanchan Pharma B/H Shell Petrol Pump, N.H. No 8, Aslali, Ahmedabad, Gujarat, 382427.
Rexroth Pharmaceutical Limited was incorporated on 15 May 2013.
The current directors of Rexroth Pharmaceutical Limited are
The primary industry of Rexroth Pharmaceutical Limited is Pharma.
Rexroth Pharmaceutical Limited is unlisted.
The authorized capital of Rexroth Pharmaceutical Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Rexroth Pharmaceutical Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX